Home › Asset managers › ProShares › 2024-2025 › Against the board
Two kinds of vote are listed: a board-sponsored proposal ProShares voted AGAINST or withheld on, and a shareholder proposal it voted FOR. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.
Everything Only shareholder proposals it backed
2,842 proposals.
| Company | Meeting | Proposal | Category | On the ballot from | ProShares voted | Funds |
|---|---|---|---|---|---|---|
| Dynatrace, Inc. | 2024-08-23 | Election of Class II Directors: Kirsten O. Wolberg | Director Elections | Board | ABSTAIN | 9 |
| Editas Medicine, Inc. | 2025-05-29 | To approve an amendment and restatement of the Company's 2015 Stock Incentive Plan. | Compensation | Board | AGAINST | 9 |
| Editas Medicine, Inc. | 2025-05-29 | To approve, on an advisory basis, the compensation paid to the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 9 |
| Enanta Pharmaceuticals, Inc. | 2025-03-13 | To approve an amendment to our 2019 Equity Incentive Plan. | Compensation | Board | AGAINST | 9 |
| Energy Vault Holdings, Inc. | 2025-05-30 | Election of Class I members of the Board of Directors: Larry Paulson | Director Elections | Board | ABSTAIN | 9 |
| Energy Vault Holdings, Inc. | 2025-05-30 | Election of Class I members of the Board of Directors: Mary Beth Mandanas | Director Elections | Board | ABSTAIN | 9 |
| Entrada Therapeutics, Inc. | 2025-06-11 | Election of Directors: Kush M. Parmar, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 9 |
| Erasca, Inc. | 2025-06-24 | To elect three directors to serve as Class I directors for a three-year term expiring at the 2028 Annual Meeting of Stockholders and until their respective successors shall have been duly elected and qualified: Jonathan E. Lim, M.D. | Director Elections | Board | ABSTAIN | 9 |
| Essential Utilities, Inc. | 2025-05-07 | To approve an advisory vote on the compensation paid to the Company's named executive officers for 2024. | Say-on-Pay | Board | AGAINST | 9 |
| FARO Technologies, Inc. | 2025-05-21 | Amendment to the FARO Technologies, Inc. 2022 Equity Incentive Plan to increase the number of shares reserved for issuance thereunder by 1,500,000. | Compensation | Board | AGAINST | 9 |
| Fastly, Inc. | 2025-06-11 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 9 |
| Fastly, Inc. | 2025-06-11 | To elect each of the Board's three nominees for director named in the accompanying proxy statement, to serve as a Class III member of the Board of Directors until the 2028 annual meeting of stockholders: Artur Bergman | Director Elections | Board | ABSTAIN | 9 |
| Fate Therapeutics, Inc. | 2025-05-29 | To approve the amendment and restatement of the Company's 2022 Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder. | Compensation | Board | AGAINST | 9 |
| Fluence Energy, Inc. | 2025-03-17 | To elect the following twelve (12) directors to hold office until the Company's 2026 Annual Meeting of Stockholders and until their respective successors have been duly elected and qualified: Cynthia Arnold | Director Elections | Board | ABSTAIN | 9 |
| Foghorn Therapeutics Inc. | 2025-06-17 | Elect Class II directors each for a three-year term: Adrian Gottschalk | Director Elections | Board | AGAINST | 9 |
| Foghorn Therapeutics Inc. | 2025-06-17 | Elect Class II directors each for a three-year term: Ian F. Smith | Director Elections | Board | AGAINST | 9 |
| IonQ, Inc. | 2025-06-17 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). | Say-on-Pay | Board | AGAINST | 9 |
| Joby Aviation, Inc. | 2025-06-06 | Election of Directors. To be elected for terms expiring in 2028: Dipender Saluja | Director Elections | Board | ABSTAIN | 9 |
| Joby Aviation, Inc. | 2025-06-06 | Election of Directors. To be elected for terms expiring in 2028: Tetsuo Ogawa | Director Elections | Board | ABSTAIN | 9 |
| Johnson Outdoors Inc. | 2025-02-27 | Election of Directors: John M. Fahey, Jr. | Director Elections | Board | ABSTAIN | 9 |
| Johnson Outdoors Inc. | 2025-02-27 | Election of Directors: Paul G. Alexander | Director Elections | Board | ABSTAIN | 9 |
| Kodiak Gas Services, Inc. | 2025-04-23 | Election of three nominees: Alex N. Darden | Director Elections | Board | ABSTAIN | 9 |
| Lamar Advertising Company | 2025-05-15 | Election of directors: Anna Reilly | Director Elections | Board | ABSTAIN | 9 |
| Lamar Advertising Company | 2025-05-15 | Election of directors: Elizabeth Thompson | Director Elections | Board | ABSTAIN | 9 |
| Lamar Advertising Company | 2025-05-15 | Election of directors: John E. Koerner, III | Director Elections | Board | ABSTAIN | 9 |
| Lamar Advertising Company | 2025-05-15 | Election of directors: Kevin P. Reilly, Jr. | Director Elections | Board | ABSTAIN | 9 |
| Lamar Advertising Company | 2025-05-15 | Election of directors: Stephen P. Mumblow | Director Elections | Board | ABSTAIN | 9 |
| Lamar Advertising Company | 2025-05-15 | Election of directors: Thomas V. Reifenheiser | Director Elections | Board | ABSTAIN | 9 |
| Lamar Advertising Company | 2025-05-15 | Election of directors: Wendell Reilly | Director Elections | Board | ABSTAIN | 9 |
| Larimar Therapeutics, Inc. | 2025-05-13 | Election of Class II Director for a Three-Year Term Expiring in 2028: Thomas E. Hamilton | Director Elections | Board | ABSTAIN | 9 |
| Lexeo Therapeutics, Inc. | 2025-06-26 | The election of Steven Altschuler and Reinaldo Diaz as Class II directors: Reinaldo Diaz | Director Elections | Board | ABSTAIN | 9 |
| Lexeo Therapeutics, Inc. | 2025-06-26 | The election of Steven Altschuler and Reinaldo Diaz as Class II directors: Steven Altschuler | Director Elections | Board | ABSTAIN | 9 |
| Lexicon Pharmaceuticals, Inc. | 2025-06-02 | Ratification and approval of the amendment to the Company's 2017 Equity Incentive Plan | Compensation | Board | AGAINST | 9 |
| Lightwave Logic, Inc. | 2025-05-15 | Election of Directors: Craig Ciesla | Director Elections | Board | ABSTAIN | 9 |
| Lyell Immunopharma, Inc. | 2025-05-15 | Election of Class I Director: Catherine Friedman | Director Elections | Board | ABSTAIN | 9 |
| MacroGenics, Inc. | 2025-05-21 | To approve the amendment to the MacroGenics, Inc. 2023 Equity Incentive Plan, as disclosed in the proxy materials. | Compensation | Board | AGAINST | 9 |
| Maplebear Inc. | 2025-05-22 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 9 |
| Maplebear Inc. | 2025-05-22 | To elect the following Class II director nominees: Ravi Gupta | Director Elections | Board | ABSTAIN | 9 |
| MaxCyte, Inc. | 2025-06-18 | To elect the Board's three nominees as identified in the accompanying Proxy Statement as Class I directors: Maher Masoud | Director Elections | Board | ABSTAIN | 9 |
| Medpace Holdings, Inc. | 2025-05-16 | Election of Directors: August J. Troendle | Director Elections | Board | ABSTAIN | 9 |
| MeiraGTx Holdings Plc | 2025-06-12 | Election of Director: Thomas E. Shenk, Ph.D. | Director Elections | Board | ABSTAIN | 9 |
| MeiraGTx Holdings Plc | 2025-06-12 | To ratify, by ordinary resolution, the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. | Audit-related | Board | AGAINST | 9 |
| MercadoLibre, Inc. | 2025-06-17 | Election of Directors: Class I Nominee: Stelleo Passos Tolda | Director Elections | Board | ABSTAIN | 9 |
| MicroStrategy Incorporated | 2025-01-21 | To approve and adopt an amendment to Article Four of the MicroStrategy Incorporated Second Restated Certificate of Incorporation to increase the number of authorized shares of class A common stock, par value $0.001 per share, from 330,000,000 shares to 10,330,000,000 shares ("Proposal 1"). | Capital Structure | Board | AGAINST | 9 |
| MicroStrategy Incorporated | 2025-01-21 | To approve and adopt an amendment to the MicroStrategy Incorporated 2023 Equity Incentive Plan to provide for automatic equity award grants to new directors upon their appointment to the Board of Directors ("Proposal 3"). | Compensation | Board | AGAINST | 9 |
| MicroStrategy Incorporated | 2025-06-12 | To elect the following eight (8) directors for the next year: Carl J. Rickertsen | Director Elections | Board | ABSTAIN | 9 |
| MicroStrategy Incorporated | 2025-06-12 | To elect the following eight (8) directors for the next year: Jarrod M. Patten | Director Elections | Board | ABSTAIN | 9 |
| MicroStrategy Incorporated | 2025-06-12 | To elect the following eight (8) directors for the next year: Michael J. Saylor | Director Elections | Board | ABSTAIN | 9 |
| MicroStrategy Incorporated | 2025-06-12 | To elect the following eight (8) directors for the next year: Phong Q. Le | Director Elections | Board | ABSTAIN | 9 |
| MicroStrategy Incorporated | 2025-06-12 | To elect the following eight (8) directors for the next year: Stephen X. Graham | Director Elections | Board | ABSTAIN | 9 |
| MicroVision, Inc. | 2025-06-06 | To approve an amendment to the 2022 MicroVision, Inc. Equity Incentive Plan. | Compensation | Board | AGAINST | 9 |
| MicroVision, Inc. | 2025-06-06 | To approve on a non-binding advisory basis the compensation of the Company's named executive officers. | Say-on-Pay | Board | AGAINST | 9 |
| Mineralys Therapeutics, Inc. | 2025-05-22 | Election of Class II directors for a three-year term to expire at the 2028 annual meeting of stockholders: Glenn P. Sblendorio | Director Elections | Board | ABSTAIN | 9 |
| MoneyLion Inc. | 2025-04-10 | to adopt the Agreement and Plan of Merger, dated as of December 10, 2024 (such agreement, as it may be amended from time to time, is referred to as the "merger agreement"), by and among MoneyLion Inc. (referred to as "MoneyLion"), Gen Digital Inc. (referred to as "Gen Digital") and Maverick Group Holdings, Inc., a wholly-owned subsidiary of Gen Digital (referred to as "Merger Sub"), pursuant to which Merger Sub will be merged with and into MoneyLion (referred to as the "merger"), with MoneyLion surviving the merger as a wholly-owned subsidiary of Gen Digital (referred to as the "merger agreement proposal"); | Extraordinary Transactions | Board | AGAINST | 9 |
| Nabors Industries Ltd. | 2025-06-03 | Approval, on a non-binding, advisory basis, of the compensation paid by the Company to its named executive officers. | Say-on-Pay | Board | AGAINST | 9 |
| Nabors Industries Ltd. | 2025-06-03 | ELECTION OF DIRECTORS: Anthony R. Chase | Director Elections | Board | ABSTAIN | 9 |
| Nabors Industries Ltd. | 2025-06-03 | ELECTION OF DIRECTORS: John P. Kotts | Director Elections | Board | ABSTAIN | 9 |
| Nabors Industries Ltd. | 2025-06-03 | ELECTION OF DIRECTORS: Tanya S. Beder | Director Elections | Board | ABSTAIN | 9 |
| Neumora Therapeutics, Inc. | 2025-05-28 | To approve the repricing of certain stock options outstanding under the 2023 Incentive Award Plan and the 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 9 |
| Neumora Therapeutics, Inc. | 2025-05-28 | To elect two Class II directors to hold office until the 2028 annual meeting of stockholders or until their successors are elected: Alaa Halawa | Director Elections | Board | ABSTAIN | 9 |
| Olema Pharmaceuticals, Inc. | 2025-06-10 | Election of the three nominees for Class II director named in the accompanying proxy statement to hold office until the Company's 2028 Annual Meeting of Stockholders and until their successors have been duly elected and qualified: Cynthia Butitta | Director Elections | Board | ABSTAIN | 9 |
| Ouster, Inc. | 2025-06-18 | Election of Class I Directors: Ernest E. Maddock | Director Elections | Board | ABSTAIN | 9 |
| Pacific Biosciences of California, Inc. | 2025-06-04 | To approve the amendment of our 2020 Equity Incentive Plan. | Compensation | Board | AGAINST | 9 |
| Pacific Biosciences of California, Inc. | 2025-06-04 | To approve, on an advisory basis, the compensation of our named executive officers. | Say-on-Pay | Board | AGAINST | 9 |
| Pliant Therapeutics, Inc. | 2025-06-05 | To approve, by non-binding advisory vote, the resolution approving Named Executive Officer compensation. | Say-on-Pay | Board | AGAINST | 9 |
| Pliant Therapeutics, Inc. | 2025-06-05 | To elect three class II directors named in the proxy statement to our Board of Directors: John Curnutte, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 9 |
| Precigen, Inc. | 2025-06-26 | Company Proposal - Approval, in compliance with Nasdaq Listing Rule 5635(c), of the additional issuance of shares of Series A Preferred Stock and Warrants to Randal J. Kirk as PIK dividends, in order for Mr. Kirk to receive PIK dividends on the Series A Preferred Stock on the same terms as the other investors. | Capital Structure | Board | AGAINST | 9 |
| Precigen, Inc. | 2025-06-26 | Company Proposal - Election of Directors: Cesar Alvarez | Director Elections | Board | AGAINST | 9 |
| Prime Medicine, Inc. | 2025-06-04 | To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Robert Nelsen | Director Elections | Board | ABSTAIN | 9 |
| Prime Medicine, Inc. | 2025-06-04 | To elect Thomas Cahill, M.D., Ph.D. and Robert Nelsen as Class III Directors: Thomas Cahill, M.D., Ph.D. | Director Elections | Board | ABSTAIN | 9 |
| Pure Storage, Inc. | 2025-06-11 | An advisory vote on our named executive officer compensation. | Say-on-Pay | Board | AGAINST | 9 |
| Pure Storage, Inc. | 2025-06-11 | Election of four Class I directors to serve until our Annual Meeting of Stockholders in 2028: Scott Dietzen | Director Elections | Board | ABSTAIN | 9 |
| Pyxis Oncology, Inc. | 2025-06-18 | The election of Class I directors named in the proxy statement: Darren Cline | Director Elections | Board | ABSTAIN | 9 |
| Pyxis Oncology, Inc. | 2025-06-18 | The election of Class I directors named in the proxy statement: Rachel Humphrey, M.D. | Director Elections | Board | ABSTAIN | 9 |
| Pyxis Oncology, Inc. | 2025-06-18 | The election of Class I directors named in the proxy statement: Santhosh Palani, Ph.D., CFA | Director Elections | Board | ABSTAIN | 9 |
| REGENXBIO Inc. | 2025-05-30 | Election of Four Class I Directors: Alexandra Glucksmann, Ph.D. | Director Elections | Board | ABSTAIN | 9 |
| REGENXBIO Inc. | 2025-05-30 | Election of Four Class I Directors: Allan M. Fox | Director Elections | Board | ABSTAIN | 9 |
| REGENXBIO Inc. | 2025-05-30 | Election of Four Class I Directors: Jennifer Zachary | Director Elections | Board | ABSTAIN | 9 |
| REGENXBIO Inc. | 2025-05-30 | To approve the REGENXBIO Inc. 2025 Equity Incentive Plan. | Compensation | Board | AGAINST | 9 |
| Riot Platforms, Inc. | 2025-06-10 | Approval, on a non-binding an advisory basis, of the compensation of the Company's Named Executive Officers. | Say-on-Pay | Board | AGAINST | 9 |
| Shoals Technologies Group, Inc. | 2025-05-01 | Approval, by an advisory vote, of the compensation of the Company's Named Executive Officers (i.e., "say-on-pay proposal). | Say-on-Pay | Board | AGAINST | 9 |
| Shoals Technologies Group, Inc. | 2025-05-01 | Election of Class I Director Nominees: Toni Volpe | Director Elections | Board | ABSTAIN | 9 |
| Shoals Technologies Group, Inc. | 2025-05-01 | Election of Class I Director Nominees: Ty Daul | Director Elections | Board | ABSTAIN | 9 |
| Skywater Technology, Inc. | 2025-05-21 | Election of Directors: Loren A. Unterseher | Director Elections | Board | ABSTAIN | 9 |
| Solaris Energy Infrastructure, Inc. | 2025-05-15 | Election of Directors: Cynthia M. Durrett | Director Elections | Board | ABSTAIN | 9 |
| Solaris Energy Infrastructure, Inc. | 2025-05-15 | Election of Directors: Ray N. Walker, Jr. | Director Elections | Board | ABSTAIN | 9 |
| Solaris Energy Infrastructure, Inc. | 2025-05-15 | Election of Directors: W. Howard Keenan, Jr. | Director Elections | Board | ABSTAIN | 9 |
| Sonoco Products Company | 2025-04-16 | Advisory (non-binding) shareholder proposal regarding transparency in political spending. | Other Social Issues | Shareholder | FOR | 9 |
| Sotera Health Company | 2025-05-21 | Elect the three following Class II director nominees to serve until the 2028 Annual Meeting of Stockholders: Ruoxi Chen | Director Elections | Board | ABSTAIN | 9 |
| Sprout Social, Inc. | 2025-05-22 | To elect three Class III directors to serve until our 2028 annual meeting of stockholders or until their successors are duly elected and qualified: Ryan Barretto | Director Elections | Board | ABSTAIN | 9 |
| Sutro Biopharma, Inc. | 2025-06-06 | Election of Class I Directors: Heidi Hunter | Director Elections | Board | ABSTAIN | 9 |
| Sutro Biopharma, Inc. | 2025-06-06 | Election of Class I Directors: Jon Wigginton, M.D. | Director Elections | Board | ABSTAIN | 9 |
| Sutro Biopharma, Inc. | 2025-06-06 | Election of Class I Directors: Michael Dybbs, Ph.D. | Director Elections | Board | ABSTAIN | 9 |
| TScan Therapeutics, Inc. | 2025-06-30 | To elect three Class I directors to the Company's Board of Directors: Garry Nicholson | Director Elections | Board | ABSTAIN | 9 |
| Tango Therapeutics, Inc. | 2025-06-05 | Election of Class I Director: Lesley Ann Calhoun | Director Elections | Board | ABSTAIN | 9 |
| Taysha Gene Therapies, Inc. | 2025-06-02 | To elect the Board's Class II Director nominees, Phillip B. Donenberg, CPA and Sukumar Nagendran, MD to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Phillip B. Donenberg, CPA | Director Elections | Board | ABSTAIN | 9 |
| Tenable Holdings, Inc. | 2025-05-14 | To elect the Board of Directors' nominees Linda Zecher Higgins and Niloofar Razi Howe, to the Board of Directors to hold office until the 2028 Annual Meeting of Stockholders: Linda Zecher Higgins | Director Elections | Board | ABSTAIN | 9 |
| Terns Pharmaceuticals, Inc. | 2025-06-11 | Election of Class I Directors for a three-year term: Hongbo Lu | Director Elections | Board | ABSTAIN | 9 |
| The Carlyle Group Inc. | 2025-05-29 | Non-Binding Vote to Approve Named Executive Officer Compensation ("Say-on-Pay") | Say-on-Pay | Board | AGAINST | 9 |
| The Trade Desk, Inc. | 2025-05-27 | The approval of The Trade Desk, Inc. 2025 Incentive Award Plan, which is an amendment and restatement of our 2016 Incentive Award Plan. | Compensation | Board | AGAINST | 9 |
← Previous Page 8 of 29 Next →
← Back to ProShares 2024-2025 overview
Built 2026-10-04 from SEC Form N-PX filings.